Integrated transcriptomic analysis and machine learning identify AURKA and CENPM as candidate biomarkers in focal segmental glomerulosclerosis
Integrierte Transkriptomanalyse und Machine Learning identifizieren AURKA und CENPM als Kandidaten-Biomarker bei fokaler segmentaler Glomerulosklerose
PLOS One · 10.11.2026 · 21 (11) · e0361466
DOI: 10.1371/journal.pone.0361466 ↗Auf einen Blick
Eine Analyse von Genexpressionsdaten bei FSGS identifizierte AURKA und CENPM als Kandidaten-Biomarker. In der Validierung zeigte AURKA die robustere diagnostische Leistung.
Fragestellung
Welche Gene eignen sich als diagnostische Biomarker bei fokaler segmentaler Glomerulosklerose (FSGS)?
Methode
Genexpressionsanalyse mit WGCNA, SVM-RFE, Random Forest und cytoHubba-MCC; ROC-Analyse; CIBERSORT; Validierung in externer Kohorte.
Ergebnisse
In GSE104948 (37 Proben; 16 FSGS, 21 Kontrollen) wurden 39 Kandidatengene gefunden. AURKA: AUC 0,95; CENPM: AUC 0,94. In GSE129973 lag die AUC bei 0,797 bzw. 0,720.
Einschränkungen
Explorative Tissue-basierte Kandidaten; funktionelle Validierung und unabhängige Bestätigung fehlen.
Schlussfolgerung der Autor:innen
Die Autor:innen identifizierten AURKA und CENPM als explorative, gewebebasierte Kandidaten-Biomarker für FSGS; AURKA war besser belegt. Vor therapeutischer Anwendung sind weitere Validierung und Bestätigung nötig.
Kernaussagen
- AURKA und CENPM wurden als Kandidaten-Biomarker identifiziert.
- Diagnostische AUC in der Trainingskohorte: 0,95 bzw. 0,94.
- Externe Validierung zeigte niedrigere AUC-Werte.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 10.11.2026. Verfasst von Xiaomei Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Machine Learning, Aurora Kinase A, Microfilament Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Focal segmental glomerulosclerosis (FSGS) is a leading cause of steroid-resistant nephrotic syndrome and progression to end-stage renal disease, but existing therapeutics and diagnostics are limited. Therefore, reliable diagnostic biomarkers that contribute to FSGS therapy and diagnostics are urgently needed.
Methods
Gene expression data for FSGS (GSE104948; 37 samples: 16 FSGS vs 21 controls) were obtained from GEO. A weighted gene co-expression network analysis (WGCNA) was employed. Key genes within significant modules were identified using Support Vector Machine Recursive Feature Elimination (SVM-RFE), random forest (RF), and cytoHubba Maximal Clique Centrality (MCC). Functional enrichment analyses were executed, while diagnostic accuracy was evaluated by receiver operating characteristic (ROC) analysis. Immune cell infiltration (ICI) levels were quantified using CIBERSORT, and validation was conducted with an independent external dataset (GSE129973; 20 FSGS vs 20 controls).
Results
The green-yellow module demonstrated robust association with the FSGS phenotype, from which 39 candidate genes were selected. Integration of RF, SVM-RFE and cytoHubba analyses pinpointed two primary hub genes: AURKA, which was recovered consistently across cross-validation folds, and CENPM, a less consistently recovered candidate. Functional enrichment underscored the involvement of these genes in pivotal biological processes, particularly mitosis and regulation of the cell cycle. Analysis of immune infiltration revealed significant shifts in the immune microenvironment (IME) of FSGS, correlating elevated expression of AURKA and CENPM with altered ICI patterns. ROC curve analyses showed the diagnostic performance of these genes, with AURKA achieving an AUC of 0.95 and CENPM 0.94 in the training dataset (independent validation: AURKA AUC 0.797, CENPM AUC 0.720). These results showed a consistent direction of change between FSGS patients and healthy controls in an independent validation cohort.
Conclusion
Using a combined analytical approach involving WGCNA, machine learning (ML) algorithms, and protein-protein interaction (PPI) networks, this study identified AURKA and CENPM as exploratory tissue-based candidate biomarkers for FSGS, with AURKA being the more robustly supported of the two; both require functional validation and independent confirmation before any therapeutic application can be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China.
- Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China.
- The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China.
ORCID-Profile: Xikui Zhang
Zitieren
APA
Lin, X., Huang, G., Sun, Q., & Zhang, X. (2026). Integrated transcriptomic analysis and machine learning identify AURKA and CENPM as candidate biomarkers in focal segmental glomerulosclerosis. PLOS One, 21(11), e0361466. https://doi.org/10.1371/journal.pone.0361466
Vancouver
Lin X, Huang G, Sun Q, Zhang X. Integrated transcriptomic analysis and machine learning identify AURKA and CENPM as candidate biomarkers in focal segmental glomerulosclerosis. PLOS One. 2026;21(11):e0361466. doi:10.1371/journal.pone.0361466
BibTeX
@article{Lin2026,
author = {Lin, Xiaomei and Huang, Guofang and Sun, Qing and Zhang, Xikui},
title = {Integrated transcriptomic analysis and machine learning identify AURKA and CENPM as candidate biomarkers in focal segmental glomerulosclerosis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361466},
doi = {10.1371/journal.pone.0361466}
}
EUVIMED